The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProspex Eng Regulatory News (PXEN)

Share Price Information for Prospex Eng (PXEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.05
Bid: 4.90
Ask: 5.20
Change: -0.05 (-0.98%)
Spread: 0.30 (6.122%)
Open: 5.10
High: 5.10
Low: 5.00
Prev. Close: 5.10
PXEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion of Loan Notes and TVR

22 Dec 2023 07:00

RNS Number : 6770X
Prospex Energy PLC
22 December 2023
 

Prospex Energy PLC / Index: AIM / Epic: PXEN / Sector: Oil and Gas

 

22 December 2023

 

Prospex Energy PLC

('Prospex' or the 'Company')

 

Conversion of Loan Note Debt and TVR

 

Prospex Energy PLC, the AIM quoted investment company focused on European gas and power projects, announces that it has received notices to convert an aggregate debt of £182,140.95 in three convertible loan notes (the "Convertible Loan Notes") in exchange for the issue of 3,311,654 new ordinary shares of 0.1p each in the Company ("Ordinary Shares") in accordance with the terms of the loan notes.

 

The abovementioned Convertible Loan Notes of original aggregate value of £500,000 were issued to three individuals and are convertible at 5.5p per share pursuant to a Convertible Loan Note Deed dated 2 September 2022. The second of three capital repayments plus accrued interest was due to be paid on 31 December 2023 and the three Convertible Loan Note holders have agreed to settle this debt by converting it into shares at the conversion price of 5.5p per share.

 

Admission to Trading and Total Voting Rights

The Company has applied to the London Stock Exchange for the admission of 3,311,654 new Ordinary Shares to trading on AIM ("Admission") as a result of the above conversion. Admission is expected to occur on or around 2 January 2024. There are currently 329,272,881 Ordinary Shares in issue. Following Admission there will be a total of 332,584,535 Ordinary Shares in issue. This will be the number of Ordinary Shares that may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

Remaining Debt in the Company

By the year end, the Company will also repay the last of three capital repayments, plus interest due on non-convertible loan notes issued in June 2021. The original amount of these loan notes was £321,680 and is held by eight Prospex shareholders. The final capital repayment plus interest to be repaid by 31 December 2023 on this instrument will be £113,715.

 

By the end of year reporting period for the Company, the above-mentioned actions will result in the Company having no long-term debt. Short-term debt will amount to £168,487 being the final quarterly repayment of the September 2022 Convertible Loan Note instrument due on 31 March 2024, unless that is also converted into shares at 5.5p. The total principal plus interest accrued to 31 March 2024, would be £175,240.

 

Mark Routh, Prospex's CEO, commented:

"In September 2022 Prospex issued Convertible Loan Notes of aggregate value of £500,000 convertible at 5.5p to three individuals to help finance the Company's development project in Italy, which is now in production and generating monthly cash-flow".

"The second capital repayment of one-third of the outstanding loans plus accrued interest was due to be repaid on 31 December 2023. I am pleased that all three Convertible Loan Note holders have again decided to take this repayment and interest in shares at the conversion price of 5.5p per share in accordance with the original term of the Notes. This demonstrates another strong vote of confidence in the Company by our supportive Convertible Loan Note holders. Unless also converted, the total remaining 5.5p Convertible Loan Notes plus interest accrued to 31 March 2024 will be £175,240 which would convert into 3,186,180 shares".

"It is satisfying to be able to go into the New Year with a much stronger balance sheet. The debt reduction coupled with cash generation from Italy and Spain means that Prospex is well positioned to capitalise on other investment opportunities with a focus on diversified European energy projects".

"As 2023 draws to a close our two producing assets in Europe continue to generate cash. Surplus funds so generated are being held and accumulated in the Company's investment and joint venture vehicles to provide funding for future projects, in particular the three wells planned in Italy and the five wells going through the permitting process in Spain. Current commitments do not require the company to raise any additional capital externally".

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

* * ENDS * *

 

 

For further information visit www.prospex.energy or contact the following:

 

 

Mark Routh

Prospex Energy PLC

Tel: +44 (0) 20 7236 1177

Ritchie BalmerRory Murphy

Strand Hanson Limited

Tel: +44 (0) 20 7409 3494

Jerry Keen

Fox-Davies Capital Limited

Tel: +44 (0) 20 3884 7447

Andrew Monk (Corporate Broking)Andrew Raca/Alex Cabral (Corporate Finance)

VSA Capital Limited

Tel: +44 (0) 20 3005 5000

Ana Ribeiro / Susie Geliher

St Brides Partners Limited 

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONTBBFTMTMTBFJ
Date   Source Headline
15th Apr 20247:00 amRNSUpdated Corporate Presentation
27th Mar 20247:00 amRNSFinal Settlement of Convertible Loan Note Debts
16th Feb 20249:02 amRNSHolding(s) in Company
31st Jan 202412:30 pmRNSItaly: Selva Field Development
19th Jan 20247:00 amRNSItaly: Selva Field Development
22nd Dec 20237:00 amRNSConversion of Loan Notes and TVR
18th Dec 20237:00 amRNSYear End Review and Business Development Update
1st Nov 20237:00 amRNSItaly: Selva Field Development - Q3 2023 Update
27th Sep 20237:00 amRNSConversion of Loan Notes and TVR
26th Sep 20237:00 amRNSConversion of Loan Note Debt and TVR
25th Sep 20237:00 amRNSConversion of Loan Notes and TVR
20th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSConversion of Loan Notes and TVR
1st Sep 20237:00 amRNSConversion of Loan Notes and TVR
29th Aug 20237:00 amRNSConversion of Loan Notes and TVR
7th Aug 20237:00 amRNSSuccessful ramp-up and commissioning of PM-1
27th Jul 20237:00 amRNSAward of Options
26th Jul 20237:00 amRNSConversion of Loan Notes and TVR
24th Jul 20237:00 amRNSNew Corporate Website
13th Jul 20238:09 amRNSConversion of Loan Notes and TVR
5th Jul 20237:45 amRNSInvestor Presentation
5th Jul 20237:00 amRNSStart of gas production from Podere Maiar-1
28th Jun 20237:00 amRNSItaly: Selva approved to commence gas production
20th Jun 202312:33 pmRNSResult of AGM
5th Jun 20237:00 amRNSAppointment of Fox-Davies as Corporate Broker
30th May 20237:00 amRNSItaly: Selva Field Development Update
26th May 20237:00 amRNSFinal Results
16th May 20238:30 amRNSSelva Field: Completion of gas plant construction
3rd May 20237:00 amRNSSpain: Project Helios Update
28th Apr 202311:04 amRNSHolding(s) in Company
19th Apr 20237:00 amRNSBoard Appointment
29th Mar 202312:14 pmRNSHolding(s) in Company
24th Mar 202312:00 pmRNSHolding(s) in Company
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSConversion of Loan Notes and TVR
1st Mar 202311:05 amRNSSecond Price Monitoring Extn
1st Mar 202311:00 amRNSPrice Monitoring Extension
1st Mar 20239:05 amRNSSecond Price Monitoring Extn
1st Mar 20239:00 amRNSPrice Monitoring Extension
28th Feb 20234:35 pmRNSPrice Monitoring Extension
28th Feb 202311:05 amRNSSecond Price Monitoring Extn
28th Feb 202311:00 amRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSAward of Options
21st Feb 20237:00 amRNSConversion of Warrants Generates £20,000
15th Feb 20237:00 amRNSConversion of Loan Notes and TVR
14th Feb 20237:00 amRNSGas Sales Agreement signed with BP Gas Marketing
7th Feb 20237:00 amRNSDirectorate Change
6th Feb 20233:21 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSConversion of Loan Notes and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.